Expertise:
Cancer Therapeutics
Speciality:
Medical Oncologist
Gender:
Male
Language:
English

Neuss served as chief medical officer at the Vanderbilt-Ingram Cancer Center from 2011 to 2018, leading it through a period of steady growth and advancement in care that contributed to the glowing reputation it has today.

The Vanderbilt-Ingram Cancer Center today sees more than 6,000 new patients annually. It is one of just 49 Comprehensive Cancer Centers designated by the National Cancer Institute in America.

Neuss retired from his duties in 2021. He first came to Vanderbilt-Ingram Cancer Center in 2011 after 25 years in Cincinnati with Oncology Hematology Care, which became the largest private practice in Southern Ohio. It grew from two to 48 doctors and received Commission Accreditation under his leadership.

An Extraordinary Resume

Neuss has been recognized internationally for his expertise in clinical care management, serving in several leadership roles for the American Society of Clinical Oncology, including chairman of the Quality Oncology Practice Steering Committee.

Neuss began practicing in 1986 after completing his fellowship and residency in Hematology/Oncology at the Duke University Medical Center, where he also received his medical degree. He received his bachelor’s degree from Michigan State University.

As chief medical officer, Neuss was instrumental in enhancing the reputation of the Vanderbilt-Ingram Cancer Center as a leader in patient-centered care, which included an increased focus on the total well-being of the person being treated.

He also is a big believer in treating mesothelioma with a collaborative approach that utilizes specialists from different disciplines.

Neuss already has seen the benefit of leaving behind his administrative duties, allowing him to focus more on each patient he sees.

On the Vanderbilt Medical Center website, patients are encouraged to publically critique the physicians who have treated them. Neuss received one of those comments in April 2019: “This dr. walks on water.”